[go: up one dir, main page]

WO2004059001A3 - Verfahren zur bestimmung von markern humaner gesichtshaut - Google Patents

Verfahren zur bestimmung von markern humaner gesichtshaut Download PDF

Info

Publication number
WO2004059001A3
WO2004059001A3 PCT/EP2003/014068 EP0314068W WO2004059001A3 WO 2004059001 A3 WO2004059001 A3 WO 2004059001A3 EP 0314068 W EP0314068 W EP 0314068W WO 2004059001 A3 WO2004059001 A3 WO 2004059001A3
Authority
WO
WIPO (PCT)
Prior art keywords
facial skin
human facial
markers
determining
cosmetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2003/014068
Other languages
English (en)
French (fr)
Other versions
WO2004059001A2 (de
Inventor
Dirk Petersohn
Kordula Schlotmann
Thomas Gassenmeier
Olaf Holtkoetter
Marcus Conradt
Kay Hofmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Priority to AU2003293839A priority Critical patent/AU2003293839A1/en
Priority to EP03789223A priority patent/EP1573064A2/de
Publication of WO2004059001A2 publication Critical patent/WO2004059001A2/de
Publication of WO2004059001A3 publication Critical patent/WO2004059001A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Die vorliegende Erfindung betrifft ein Verfahren zur Bestimmung der Homeostase humaner Gesichtshaut in vitro, Test-Kits und Biochips zur Bestimmung von Markern humaner Gesichtshaut sowie die Verwendung von Proteinen, mRNA-Molekülen oder Fragmenten von Proteinen oder mRNA-Molekülen als Marker humaner Gesichtshaut; ferner ein Testverfahren zum Nachweis der Wirksamkeit von kosmetischen oder pharmazeutischen Wirkstoffen zur Behandlung humaner Gesichtshaut sowie ein Screening-Verfahren zur Identifikation von kosmetischen oder pharmazeutischen Wirkstoffen zur Behandlung humaner Gesichtshaut und ein Verfahren zur Herstellung einer kosmetischen oder pharmazeutischen Zubereitung zur Behandlung humaner Gesichtshaut.
PCT/EP2003/014068 2002-12-20 2003-12-11 Verfahren zur bestimmung von markern humaner gesichtshaut Ceased WO2004059001A2 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2003293839A AU2003293839A1 (en) 2002-12-20 2003-12-11 Method for determining markers of human facial skin
EP03789223A EP1573064A2 (de) 2002-12-20 2003-12-11 Verfahren zur bestimmung von markern humaner gesichtshaut

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10260928.4 2002-12-20
DE2002160928 DE10260928A1 (de) 2002-12-20 2002-12-20 Verfahren zur Bestimmung von Markern humaner Gesichtshaut

Publications (2)

Publication Number Publication Date
WO2004059001A2 WO2004059001A2 (de) 2004-07-15
WO2004059001A3 true WO2004059001A3 (de) 2005-03-03

Family

ID=32477976

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2003/014068 Ceased WO2004059001A2 (de) 2002-12-20 2003-12-11 Verfahren zur bestimmung von markern humaner gesichtshaut

Country Status (4)

Country Link
EP (1) EP1573064A2 (de)
AU (1) AU2003293839A1 (de)
DE (1) DE10260928A1 (de)
WO (1) WO2004059001A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2866233B1 (fr) * 2004-02-18 2008-02-08 Vincience Composition dermatologique et/ou cosmetique contenant des polypeptides
FR2948021A1 (fr) * 2009-07-16 2011-01-21 Oreal Utilisation cosmetique de polypeptides de type lacritine
JP2016530886A (ja) * 2013-08-30 2016-10-06 ザ プロクター アンド ギャンブル カンパニー 眼窩周囲色素異常症を処置するための美容成分を同定するための方法及びそれらのためのシステム
EP3093343B1 (de) * 2014-01-10 2020-01-01 Juntendo Educational Foundation Verfahren zur beurteilung des metastatischen potenzials von lymphknoten von endometriumkrebs
NO344051B1 (en) * 2017-05-04 2019-08-26 Patogen As Novel virus in Fish and Method for detection

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001091700A2 (en) * 2000-05-30 2001-12-06 Connective Tissue Imagineering Llc Composition and method for enhancing elasticity of tissue
WO2002053773A2 (de) * 2001-01-03 2002-07-11 Henkel Kommanditgesellschaft Auf Aktien Verfahren zur bestimmung des hautstress oder der hautalterung in vitro
WO2002053778A2 (en) * 2001-01-05 2002-07-11 Genomicfx, Inc. Method for relative quantification of attached nucleic acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
IL139393A0 (en) * 1998-05-04 2001-11-25 Fraunhofer Ges Forschung Method and device for isolating nucleic acids
DE19819889A1 (de) * 1998-05-04 1999-11-11 Fraunhofer Ges Forschung Verfahren zur Isolierung von Nucleinsäuren

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001091700A2 (en) * 2000-05-30 2001-12-06 Connective Tissue Imagineering Llc Composition and method for enhancing elasticity of tissue
WO2002053773A2 (de) * 2001-01-03 2002-07-11 Henkel Kommanditgesellschaft Auf Aktien Verfahren zur bestimmung des hautstress oder der hautalterung in vitro
WO2002053778A2 (en) * 2001-01-05 2002-07-11 Genomicfx, Inc. Method for relative quantification of attached nucleic acids

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
See also references of EP1573064A2 *
WATSON RACHEL E B ET AL: "A short-term screening protocol, using fibrillin-1 as a reporter molecule, for photoaging repair agents", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 116, no. 5, May 2001 (2001-05-01), pages 672 - 678, XP002283191, ISSN: 0022-202X *

Also Published As

Publication number Publication date
AU2003293839A1 (en) 2004-07-22
WO2004059001A2 (de) 2004-07-15
DE10260928A1 (de) 2004-07-08
EP1573064A2 (de) 2005-09-14

Similar Documents

Publication Publication Date Title
WO2002053773A3 (de) Verfahren zur bestimmung des hautstress oder der hautalterung in vitro
WO2002053774A3 (de) Verfahren zur bestimmung der homeostase der haut
EP2639301A3 (de) Polynukleotide zur Kodierung neuartiger PCSK9-Varianten
WO2005012337A3 (en) Antigenic peptides of sars coronavirus and uses thereof
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2003076592A3 (en) Novel method for delivery and intracellular synthesis of sirna molecules
CA2321664A1 (en) Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
WO2004106495A3 (en) Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
WO2005040421A3 (en) Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues
WO2003016464A3 (en) Cancer specific oligosaccharide sequences and use thereof
WO2007134350A3 (en) Antibodies specific for bet v 1 and use thereof in the prevention and treatment of bet v 1-induced diseases
WO2005034889A3 (en) Method for imparting artificial tan to human skin
WO2005000335A3 (en) Use of genes differentially expressed during aging of liver for treatment and diagnosis
EP2083018A3 (de) Zusammensetzungen und Verfahren mit Bezug zu STOP-1
WO2004059002A3 (de) Verfahren zur bestimmung der homeostase behaarter haut
WO2004059001A3 (de) Verfahren zur bestimmung von markern humaner gesichtshaut
WO2004100886A3 (en) POLYNUCLEOTIDES AND POLYPEPTIDES ASSOCIATED WITH THE NF-kB PATHWAY
EA200601288A1 (ru) Производные 1,3-дифенилпроп-2-ен-1-она, способ их получения и применение
WO2002046767A3 (en) Diagnosis and treatment of alzheimer's disease
WO2005089310A3 (en) Breath test for oral malodor
WO2001007479A3 (en) Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases
WO2002031496A3 (de) Verfahren zur in vitro bestimmung der hautalterung
WO2002054078A3 (de) Verfahren zur bestimmung der hautalterung in vitro
WO2004005540A3 (de) Verwendungen von an ngal bindenden substanzen zur diagnose und behandlung von krebserkrankungen
WO2005028671A3 (de) Verfahren zur bestimmung von haarzyklus-markern

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR BY CA CN DZ EG ID IL IN JP KR MX NO NZ PL RU SG UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003789223

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003789223

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP